Neoadjuvant carboplatin and ifosfamide chemotherapy for inoperable FIGO stage III and IV ovarian carcinoma

This publication has 13 references indexed in Scilit:

• Meta-analysis of surgery in advanced ovarian carcinoma: Ismaximum cytoreductive surgery an independent determinant of prognosis?
  American Journal of Obstetrics and Gynecology, 1992
• Treatment of advanced ovarian cancer: 10 years of experience
  Annals of Oncology, 1992
• Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.
  BMJ, 1991
• Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
  Journal of Clinical Oncology, 1989
• A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk)) as main objectives
  European Journal of Cancer and Clinical Oncology, 1989
• Sequential cisplatin/cyclophosphamide chemotherapy and abdominopelvic radiotherapy in the management of advanced ovarian cancer
  British Journal of Cancer, 1988
• Speed of response to platinum-based chemotherapy: Implications for the management of epithelial ovarian cancer
  European Journal of Cancer and Clinical Oncology, 1987
• High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer (FIGO stages III and IV): report from the North Thames Cooperative Group.
  BMJ, 1985
• Ifosfamide-pharmacology, safety and therapeutic potential
  Cancer Treatment Reviews, 1985
• Cancer of the ovary
  American Journal of Obstetrics and Gynecology, 1970